These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2769962)

  • 1. [Seizure and tremor occurring in acute leukemia patients treated with imipenem/cilastatin].
    Fujishita M; Kataoka R; Eguchi T; Miyagi T; Kotani S; Takeuchi T; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1989 Mar; 30(3):392-5. PubMed ID: 2769962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
    Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
    Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizure propensity with imipenem.
    Brown RB; Sands M; Morris AB
    Arch Intern Med; 1990 Jul; 150(7):1551. PubMed ID: 2369261
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system.
    Pestotnik SL; Classen DC; Evans RS; Stevens LE; Burke JP
    Ann Pharmacother; 1993 Apr; 27(4):497-501. PubMed ID: 8477128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complication during imipenem/cilastatin therapy in uraemic patients.
    Campise M
    Nephrol Dial Transplant; 1998 Jul; 13(7):1895-6. PubMed ID: 9681765
    [No Abstract]   [Full Text] [Related]  

  • 6. Seizure activity associated with imipenem use: clinical case reports and review of the literature.
    Leo RJ; Ballow CH
    DICP; 1991 Apr; 25(4):351-4. PubMed ID: 1926901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem/cilastatin-induced acute eosinophilic pneumonia.
    Foong KS; Lee A; Pekez M; Bin W
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26944380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of imipenem/cilastatin in neurocritical care patients.
    Hoffman J; Trimble J; Brophy GM
    Neurocrit Care; 2009; 10(3):403-7. PubMed ID: 19116700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem.
    Wu Y; Chen K; Shi Z; Wang Q
    Curr Pharm Biotechnol; 2014; 15(8):685-90. PubMed ID: 25051950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem-cilastatin-induced psychosis: a case report.
    Ninan J; George GM
    J Med Case Rep; 2016 Apr; 10(1):107. PubMed ID: 27118305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures related to use of imipenem-cilastatin.
    Lane M; Kania D; Rapp RP
    Am J Health Syst Pharm; 1996 Jul; 53(13):1605-6. PubMed ID: 8809285
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual cause of seizures during subarachnoid anesthesia in a patient undergoing transurethral resection of the prostate: a case report.
    Galante D
    Minerva Anestesiol; 2009 Apr; 75(4):221-3. PubMed ID: 19078902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients.
    Turhal NS
    J Chemother; 1999 Oct; 11(5):410-3. PubMed ID: 10632390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI; Fung CP; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imipenem/cilastatin-induced acute thrombocytopenia].
    Alegre Herrera S; Quirós Valera M; Rodríguez Fernández A
    Med Clin (Barc); 2001 Jul; 117(5):197-8. PubMed ID: 11481089
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin.
    Guglielmo BJ; Jacobs RA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2097-8. PubMed ID: 8870902
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug utilization evaluation of imipenem/cilastatin in patients with renal dysfunction.
    Sheakely ML; Nicolau DP; Agner SI
    Ann Pharmacother; 1993; 27(7-8):981-2. PubMed ID: 8364293
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbapenems in serious infections: a risk-benefit assessment.
    Norrby SR
    Drug Saf; 2000 Mar; 22(3):191-4. PubMed ID: 10738843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment.
    Badiou S; Bellet H; Lehmann S; Cristol JP; Jaber S
    Clin Chem Lab Med; 2005; 43(3):332-4. PubMed ID: 15843241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of superinfection following imipenem/cilastatin therapy in hospitalised patients with acute exacerbations of severe chronic obstructive pulmonary disease.
    Ding X; Wu X; Peng Y; Hu S; Nie H
    Int J Clin Pract; 2006 Jul; 60(7):806-11. PubMed ID: 16858755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.